Cargando…
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
BACKGROUND: The manipulation of dendritic cells (DCs) for cancer vaccination has not reached its full potential, despite the revolution in cancer immunotherapy. DCs are fundamental for CD8+ T cell activation, which relies on cross-presentation of exogenous antigen on MHC-I and can be fostered by imm...
Autores principales: | Wculek, Stefanie K., Amores-Iniesta, Joaquín, Conde-Garrosa, Ruth, Khouili, Sofía C., Melero, Ignacio, Sancho, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454603/ https://www.ncbi.nlm.nih.gov/pubmed/30961656 http://dx.doi.org/10.1186/s40425-019-0565-5 |
Ejemplares similares
-
Metabolic Control of Dendritic Cell Functions: Digesting Information
por: Wculek, Stefanie K., et al.
Publicado: (2019) -
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
por: Bol, Kalijn F., et al.
Publicado: (2019) -
Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-Resident Memory CD8(+) T Cells
por: Enamorado, Michel, et al.
Publicado: (2018) -
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
por: Cueto, Francisco J, et al.
Publicado: (2021) -
Batf3-dependent CD103(+) dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice
por: Martínez-López, María, et al.
Publicado: (2015)